MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cerebellum"

  • 2024 International Congress

    CANVAS and Sleep Disorder: a Prospective Cross-Sectional Study

    A. Funcis, G. Dalla Zanna, S. Rossi, F. Madia, G. Silvestri, V. Brunetti (Rome, Italy)

    Objective: Aim in this study is to characterize, for the first time, sleep and its disorders in patients with CANVAS genetically confirmed. Background: Cerebellar ataxia,…
  • 2024 International Congress

    Pulmonary Dysfunction in Friedreich’s Ataxia (FRDA)

    T. Zesiewicz, T. Vu, A. Patel, T. Mcdonald, Y. Huang, Y. Zhao, L. Campbell, L. Evans, D. Mohan, C. Gooch, K. Calero (Tampa, USA)

    Objective: We sought to characterize pulmonary function in FRDA and identify disease variables that may contribute to dysfunction. Background: FRDA is a neurodegenerative disease that causes…
  • 2024 International Congress

    Opsoclonus after Covid-19 infection

    F. Sakeff, A. Vilar (São Paulo, Brazil)

    Objective: Describe the first Brazilian case of opsoclonus due to COVID-19 infection Background: Opsoclonus-myoclonus is a rare movement disorder associated with a variety of conditions,…
  • 2024 International Congress

    Spinocerebellar Ataxia Type 4: a Novel Polyglycine Disease caused by GGC Repeat Expansion in ZFHX3.

    S. Pulst (slc, USA)

    Objective: Identification of the mutation causing SCA4. Background: SCA4 is an autosomal dominant disease, originally described in a large Utah pedigree, characterized by sensory and…
  • 2024 International Congress

    Assessment of Cerebellar Ataxia Severity in Patients with Posterior Cranial Fossa Tumors Using CASAS Scale

    D. Khodjimetov (Tashkent, Uzbekistan)

    Objective: To develop a scale for assessing the severity of cerebellar ataxia in patients with PCFT Background: Cerebellar ataxia (CA) is prevalent in patients with…
  • 2024 International Congress

    Atypical spinocerebellar ataxia (SCA) type 16 as initial presenting migraine and mild ataxia with cerebellar atrophy

    W. Yoon (Seoul, Republic of Korea)

    Objective: Our aim is to report an atypical case of initial manifestation of spinocerebellar ataxia type 16, which showed migraine and mild ataxia with cerebellar…
  • 2024 International Congress

    Seminoma resulting in rapidly progressive cerebellar syndrome with associated dual positive kelch-like protein 11 (KLHL11) IgG and leucine zipper 4 (LUZP4)–immunoglobulin G (IgG) antibodies.

    R. Orie, V. Suski, G. Quiroga-Garza, J. Linnoila (Pittsburgh, USA)

    Objective: We describe a case of retroperitoneal seminoma resulting in paraneoplastic progressive cerebellar syndrome secondary to KLHL11 and LUZP4 antibodies. Background: Testicular cancer covers a…
  • 2024 International Congress

    Cervical dystonia after cerebellar stroke and medullary hemorrhage

    I. Sarac, H. Sarac, F. Borovecki, N. Henigsberg, Z. Kresic (Zagreb, Croatia)

    Objective: to present a patient who developed delayed secondary cervical dystonia after anterior medullary hemorrhage and ipsilateral cerebellar stroke. Background: Postroke dystonia is mostly associated…
  • 2024 International Congress

    Increased cerebellar grey matter in writer’s cramp patients: a morphometric signature of symptom compensation

    K. Witt, V. Yogeswaran, J. Stalter, A. Knutzen, A. Baumann, K. Zeuner (Oldenburg, Germany)

    Objective: This study focused on grey matter changes in the cerebellum by performing voxel-based morphometry (VBM) on infratentorial MRI scans of writers' cramp (WC) patients,…
  • 2024 International Congress

    Brain De-Ironization with Nasal Spray of Iron Chelator in Treatment of Multiple System Atrophy, a Case Trial

    A. Amoushahi, A. Sahebkar, P. Moeini, N. Chitsaz (Isfahan, Islamic Republic of Iran)

    Objective: Iron removal seems to be a treatment approach in Multiple system atrophy (MSA) because pathological findings shows the accumulation of iron and α-synuclein protein…
  • 1
  • 2
  • 3
  • …
  • 18
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley